Company intelligence / Profile preview

Kemp Proteins

Frederick, Maryland, United Stateskempproteins.com ↗

Ownership: Private
Development stage: Other

Overview

Kemp Proteins provides gene-to-protein bioservices supporting research through to clinical applications. They have completed over 20,000 projects with expertise in multiple expression systems for recombinant protein and antibody production. No direct clinical results as they do not develop their own drugs.

Modalities: Recombinant proteinMonoclonal antibodyAntibodyProtein
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Kemp Proteins.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kemp Proteins.

Explore the full profile